Last updated 2026-07-20
- Raised $1.3M Pre-Seed round, May 2024
- Raised Seed round led by Adama Ventures, Sep 2025
Total raised
$1.3M
Last: Seed 2025-10
Stage
Pre-Seed
Founded
2022
Headcount
30
HQ
Moshav Gimzo, Israel
Sector
Health Tech & Life Sciences
About
Epilog is an Israeli startup that develops artificial intelligence-based tools to help people manage complex challenges and make quality-of-life-oriented medical decisions in the later stages of life. Their platform leverages behavioral economics and digital engagement strategies to identify unmet needs, manage physical symptoms, and facilitate challenging conversations about care transitions. The company aims to transition patients and healthcare organizations from reactive disease management to personalized, quality-of-life care. Epilog's AI platform supports complex chronic patients and their families through rich dialogue, real-time monitoring with intervention alerts, clinician tools, and decision support. They were founded in 2022.
Funding history · 2 rounds · $1.3M total
2025-09
Seed
Undisclosed
★ Adama Ventures
2024-05
Pre-Seed
$1.3M
Headcount over time
From 6 (2024-03) to 18 (2026-03) · +12 (+200%) · 7 points · source: Finder history + radar grounding
Q&A
- What is Epilog's primary focus?
- Epilog aims to redefine care in life's last chapter, focusing on improving quality of life and reducing the economic burden associated with end-of-life decision-making, particularly the surge in hospital utilization rates.
- When was Epilog founded?
- Epilog was founded in June 2022.
- What is the total amount of funding Epilog has raised to date?
- Epilog has raised a total of $1,300,000.
- When did Epilog complete its Pre-Seed funding round?
- Epilog completed a Pre-Seed funding round in June 2024, raising $1,300,000.
- Which investor participated in Epilog's Seed funding round in October 2025?
- Adama Ventures participated in Epilog's Seed funding round in October 2025.
- Who are the co-founders of Epilog?
- The co-founders of Epilog are Tal Shapsa Heiman (Co-founder & CEO) and Or Bar Tal (Co-founder & CTO).
- What is Dan Ariely's role at Epilog?
- Dan Ariely serves as the Chief Behavioral Officer at Epilog.
- What is Epilog's primary sector classification?
- Epilog's primary sector classification is Health Tech & Life Sciences.
Team · 6
Tal Shapsa-Heiman
Founder · CEO & Co-Founder
Ofir Shauman
Founder · CPO & Co-Founder
Or Bar-Tal
Founder · CTO & Co-Founder
Prof. Dan Arieli
Founder · Chief Behavioral Officer & Co-Founder
Dr. Ron Tzbar
Founder · CMO & Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Engagement
Technologies
Platforms & InterfacesMobileArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersInsurance CompaniesConsumers
Business model
B2B2C
Highlights
Verified
Tags
digital-healthcarepatient-engagementdisease-managementhealth-informationhealth-insurance
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | epilog.world/ |
|---|---|
| linkedin.com/company/96403746 | |
| facebook.com/epilog.world |
Identifiers & details
| Legal name | Epilog END of Life Companion Ltd. |
|---|---|
| Founded | 2022 |
| Employees (exact) | 30 |
Radar intelligence
Patents
| EPO | 14 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | epilog.world |
|---|
Certificate / subdomain footprint
| Subdomains | 79 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516629003 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-06-13 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — shares_capital (2), annual_report (1), people (1) |
| Registered address | הארבעה 19 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-29 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |
| 2025-09-28 | דו~ח שנתי |
| 2026-01-14 | עדכון דירקטורים-הוספת דירקטור |
| 2026-01-04 | הקצאת מניות |